
TY  - JOUR
TI  - Abstracts PDS
JO  - Allergy
JA  - Allergy
VL  - 74
IS  - S106
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.13959
DO  - doi:10.1111/all.13959
SP  - 130
EP  - 331
PY  - 2019
ER  - 

TY  - JOUR
TI  - MEETING ABSTRACTS
JO  - Cell Biology International
VL  - 24
IS  - 12
SN  - 1065-6995
UR  - https://doi.org/10.1006/cbir.2000.0671
DO  - doi:10.1006/cbir.2000.0671
SP  - 913
EP  - 1012
PY  - 2000
ER  - 

TY  - JOUR
TI  - Poster Presentation Abstracts
JO  - International Journal of Rheumatic Diseases
JA  - Int J Rheum Dis
VL  - 20
IS  - S1
SN  - 1756-1841
UR  - https://doi.org/10.1111/1756-185X.13178
DO  - doi:10.1111/1756-185X.13178
SP  - 17
EP  - 131
PY  - 2017
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - HIV Medicine
JA  - HIV Med
VL  - 15
IS  - S3
SN  - 1464-2662
UR  - https://doi.org/10.1111/hiv.12147
DO  - doi:10.1111/hiv.12147
SP  - 17
EP  - 159
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstracts of the IPITA-IXA-CTS 2015 Joint Congress November 15–19, 2015, Melbourne, Australia
JO  - Xenotransplantation
JA  - Xenotransplantation
VL  - 22
IS  - S1
SN  - 0908-665X
UR  - https://doi.org/10.1111/xen.12207
DO  - doi:10.1111/xen.12207
SP  - S185
EP  - S201
PY  - 2015
ER  - 

TY  - JOUR
AU  - Schwartz, Joseph
AU  - Winters, Jeffrey L.
AU  - Padmanabhan, Anand
AU  - Balogun, Rasheed A.
AU  - Delaney, Meghan
AU  - Linenberger, Michael L.
AU  - Szczepiorkowski, Zbigniew M.
AU  - Williams, Mark E.
AU  - Wu, Yanyun
AU  - Shaz, Beth H.
TI  - Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
JO  - Journal of Clinical Apheresis
JA  - J. Clin. Apheresis
VL  - 28
IS  - 3
SN  - 0733-2459
UR  - https://doi.org/10.1002/jca.21276
DO  - doi:10.1002/jca.21276
SP  - 145
EP  - 284
KW  - apheresis
KW  - plasma exchange
KW  - immunoadsorption
KW  - leukocytapheresis
KW  - photopheresis
KW  - categories
KW  - indications
KW  - evidence based
KW  - red blood cell exchange
KW  - LDL apheresis
KW  - rheopheresis
PY  - 2013
AB  - The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is charged with reviewing, updating and categorizating indications for therapeutic apheresis. Beginning with the 2007 ASFA Special Issue (Fourth Edition), the committee has incorporated systematic review and evidence-based approach in the grading and categorization of indications. This Sixth Edition of the ASFA Special Issue has further improved the process of using evidence-based medicine in the recommendations by consistently applying the category and GRADE system definitions, but eliminating the ?level of evidence? criteria (from the University HealthCare Consortium) utilized in prior editions given redundancy between GRADE and University HealthCare Consortium systems. The general layout and concept of a fact sheet that was utilized in the Fourth and Fifth Editions, has been largely maintained in this edition. Each fact sheet succinctly summarizes the evidence for the use of therapeutic apheresis in a specific disease entity. This article consists of 78 fact sheets (increased from 2010) for therapeutic indications in ASFA categories I through IV, with many diseases categorized having multiple clinical presentations/situations which are individually graded and categorized. J. Clin. Apheresis 28:145?284, 2013. ? 2013 Wiley Periodicals, Inc.
ER  - 

TY  - JOUR
TI  - ISBRA ABSTACTS
JO  - Alcoholism: Clinical and Experimental Research
VL  - 30
IS  - s2
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.2006.00197.x
DO  - doi:10.1111/j.1530-0277.2006.00197.x
SP  - 45A
EP  - 182A
PY  - 2006
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - The FEBS Journal
JA  - FEBS J
VL  - 282
IS  - S1
SN  - 1742-464X
UR  - https://doi.org/10.1111/febs.13339
DO  - doi:10.1111/febs.13339
SP  - 55
EP  - 422
PY  - 2015
ER  - 

TY  - JOUR
TI  - FREE COMMUNICATIONS  POSTER COMMUNICATIONS
JO  - Nephrology
VL  - 10
IS  - s1
SN  - 1320-5358
UR  - https://doi.org/10.1111/j.1440-1797.2005.00420.x
DO  - doi:10.1111/j.1440-1797.2005.00420.x
SP  - A117
EP  - A232
PY  - 2005
ER  - 

TY  - JOUR
TI  - AASLD Abstracts
JO  - Hepatology
JA  - Hepatology
VL  - 56
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.26040
DO  - doi:10.1002/hep.26040
SP  - 191A
EP  - 1144A
PY  - 2012
ER  - 

AU  - Brady, Colin M.
AU  - Chaikof, Elliot L.
C7  - pp. 533-553
TI  - Open Repair of Abdominal Aortic Aneurysms
SN  - 9781444330717
UR  - https://doi.org/10.1002/9781118481370.ch41
DO  - doi:10.1002/9781118481370.ch41
SP  - 533-553
KW  - Abdominal aortic aneurysm
KW  - Aneurysm complications
KW  - Aneurysm diagnosis
KW  - Aneurysm pathogenesis
KW  - Aneurysm screening
KW  - Aneurysm surgery
KW  - Aneurysm surveillance
KW  - Aneurysm treatment
KW  - Open aneurysmorrhaphy
KW  - Ruptured aneurysm
PY  - 2012
AB  - Summary The clinical entity of abdominal aortic aneurysm (AAA) is characterized by a localized dilation of the subdiaphragmatic aorta greater than or equal to 1.5 times the diameter of the normal segment. In the presence of progressive aneurysm enlargement, the greatest clinical concern remains that of rupture. Primary prevention of modifiable risk factors, as well as timely identification and intervention before rupture can occur, are the primary components of the surgeon's armamentarium to mitigate mortality from this disease entity. In this chapter, we endeavor to provide a review of the pathophysiology, risk factors, screening, diagnostic, surveillance, and treatment modalities relevant to the care of the patient with abdominal aortic aneurysm.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - British Journal of Haematology
VL  - 157
IS  - s1
SN  - 9781444330717
UR  - https://doi.org/10.1111/j.1365-2141.2012.09071.x
DO  - doi:10.1111/j.1365-2141.2012.09071.x
SP  - 1
EP  - 88
PY  - 2012
ER  - 

TY  - JOUR
TI  - Clinical care and other categories posters: Audit
JO  - Diabetic Medicine
VL  - 26
IS  - s1
SN  - 9781444330717
UR  - https://doi.org/10.1111/j.1464-5491.2009.02663.x
DO  - doi:10.1111/j.1464-5491.2009.02663.x
SP  - 79
EP  - 199
PY  - 2009
ER  - 

TY  - JOUR
TI  - Full Oral
JO  - Transplant International
JA  - Transpl Int
VL  - 32
IS  - S2
SN  - 9781444330717
UR  - https://doi.org/10.1111/tri.13507
DO  - doi:10.1111/tri.13507
SP  - 7
EP  - 126
PY  - 2019
ER  - 

TY  - JOUR
TI  - Invited Speaker’s Abstracts
JO  - Tropical Medicine & International Health
VL  - 16
IS  - s1
SN  - 9781444330717
UR  - https://doi.org/10.1111/j.1365-3156.2011.02858.x
DO  - doi:10.1111/j.1365-3156.2011.02858.x
SP  - 8
EP  - 54
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Fundamental & Clinical Pharmacology
JA  - Fundam Clin Pharmacol
VL  - 28
IS  - s1
SN  - 9781444330717
UR  - https://doi.org/10.1111/fcp.12066
DO  - doi:10.1111/fcp.12066
SP  - 91
EP  - 114
PY  - 2014
ER  - 

TY  - JOUR
TI  - Research Podium Abstracts
JO  - Value in Health
VL  - 12
IS  - 3
SN  - 9781444330717
UR  - https://doi.org/10.1111/j.1524-4733.2009.00537_1.x
DO  - doi:10.1111/j.1524-4733.2009.00537_1.x
SP  - A1
EP  - A19
PY  - 2009
ER  - 

TY  - JOUR
C8  - PNS-15-04-00041.R3
TI  - Abstracts
JO  - Journal of the Peripheral Nervous System
JA  - J Peripher Nerv Syst
VL  - 21
IS  - S1
SN  - 9781444330717
UR  - https://doi.org/10.1111/jns.12166
DO  - doi:10.1111/jns.12166
SP  - S3
EP  - S36
PY  - 2016
ER  - 

TY  - JOUR
TI  - Index Volumes to 459_474-481
JO  - The Journal of Physiology
VL  - 481
IS  - index
SN  - 9781444330717
UR  - https://doi.org/10.1113/jphysiol.1995.sp020409
DO  - doi:10.1113/jphysiol.1995.sp020409
SP  - 21
EP  - 78
PY  - 1995
ER  - 

TY  - JOUR
TI  - Abstracts Cardiopulmonary
JO  - Artificial Organs
VL  - 27
IS  - 4
SN  - 9781444330717
UR  - https://doi.org/10.1046/j.1525-1594.2003.00011.x
DO  - doi:10.1046/j.1525-1594.2003.00011.x
SP  - 300
EP  - 347
PY  - 2003
ER  - 
